Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05491668 · ClinicalTrials.gov registry record

Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI

A clinical trial of Coronary Artery Disease, sponsored by Beth Israel Deaconess Medical Center.

Recruiting
Registry status
107
Enrollment target
1
Study location

NCT05491668: Recruiting study of Coronary Artery Disease, sponsored by Beth Israel Deaconess Medical Center.

NCT05491668 is a study of Coronary Artery Disease that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 107 participants, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05491668, a study of Coronary Artery Disease, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.

RECRUITING
Registry status
107 participants
Enrollment target
1
Study location

Study Summary

Traditionally, the severity of a blockage (stenosis) in a coronary artery has been determined by visual angiographic assessment of the diameter of the artery at the level of a blockage compared to a normal healthy area of the same artery. With the advent of invasive physiological testing to assess coronary blood flow, multiple clinical trials have demonstrated a clinical benefit to a physiology-guided percutaneous coronary intervention (PCI) approach. However, despite this and the potential for significant variation in the interpretation of coronary artery stenosis severity by visual angiography alone to guide PCI, invasive physiologic indices remain significantly under-utilized. The purpose of this study is to investigate the physiologic significance of coronary lesions deemed angiographically severe by visual estimation that are planned for PCI. The investigators plan to perform blinded physiologic assessment pre and post PCI. The primary aim of the study is to determine whether a subset of lesions visually estimated as severe by angiography treated with stent placement/PCI may in fact not be physiologically significant when assessed invasively, and thus PCI could safely be deferred in these patients. A secondary aim is to evaluate physiologic assessment post PCI to detect residual ischemia that could be utilized to optimize stent placement.

Primary Outcome

Non-significant lesions defined as a diastolic pressure ratio (dPR) \</= 0.89 (range 0-1), expressed as mean, standard deviation, and percentage of total number of assessments

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Non-hyperemic pressure ratio assessment pre and post PCI

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 107 participants
Start Date 2022-10-11
Est. Completion 2026-06

What NCT05491668 shows while recruiting

NCT05491668 is an observational study that tracks outcomes without assigning an intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (92% lower).

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Non-hyperemic pressure ratio assessment pre and post PCI is the first listed.

NCT05491668 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05491668 about?

NCT05491668 is a clinical study titled "Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI". Traditionally, the severity of a blockage (stenosis) in a coronary artery has been determined by visual angiographic assessment of the diameter of the artery at the level of a blockage compared to a normal healthy area of the same artery. With the advent of invasive physiological testing to assess c...

What is the current status of trial NCT05491668?

This trial is currently recruiting. The enrollment target is 107 participants. The study started on 2022-10-11. Estimated completion is 2026-06.

What conditions does trial NCT05491668 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT05491668?

The interventions under investigation include: Non-hyperemic pressure ratio assessment pre and post PCI (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05491668?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05491668 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05491668's enrollment target sits among peer trials

107 143rd of 219 higher than 76 of 219 other Coronary Artery Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06041594 · 107 participants · NA

    Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)

  • NCT06081426 · 107 participants · NA

    Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)

  • NCT06527599 · 107 participants · NA

    Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention

  • NCT07096193 · 107 participants · Phase 1

    Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05491668, the US trial registry maintained by the National Library of Medicine. NCT05491668 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.